Search

Author/Creator Devalaraja, Matt

1. FP379ERYTHROFERRONE PREDICTS MORTALITY AND CARDIOVASCULAR EVENTS IN CKD AND IN HEMODIALYSIS PATIENTS: A TWO COHORTS STUDY. (13th June 2019)

Authors:
Spoto, Belinda; Pizzini, Patrizia; Torino, Claudia; Leonardis, Daniela; Cutrupi, Sebastiano; Tripepi, Giovanni; Lo, Larry; Devalaraja, Matt; Mallamaci, Francesca; Kakkar, Rahul; Zoccali, Carmine
Journal:
Nephrology dialysis transplantation
Issue:
Volume 34(2019)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10289 (29th May 2021)

Authors:
Ridker, Paul M; Devalaraja, Matt; Baeres, Florian M M; Engelmann, Mads D M; Hovingh, G Kees; Ivkovic, Milana; Lo, Larry; Kling, Douglas; Pergola, Pablo; Raj, Dominic; Libby, Peter; Davidson, Michael
Journal:
Lancet
Issue:
Volume 397:Issue 10289(2021)
Page Start:
2060
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study. (14th May 2019)

Authors:
Markousis‐Mavrogenis, George; Tromp, Jasper; Ouwerkerk, Wouter; Devalaraja, Matt; Anker, Stefan D.; Cleland, John G.; Dickstein, Kenneth; Filippatos, Gerasimos S.; van der Harst, Pim; Lang, Chim C.; Metra, Marco; Ng, Leong L.; Ponikowski, Piotr; Samani, Nilesh J; Zannad, Faiez; Zwinderman, Aeilko...
Journal:
European journal of heart failure
Issue:
Volume 21:Number 8(2019)
Page Start:
965
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗